318 related articles for article (PubMed ID: 2514093)
1. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
Lawrence D; Strandberg L; Grundström T; Ny T
Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.
Reilly TM; Seetharam R; Duke JL; Davis GL; Pierce SK; Walton HL; Kingsley D; Sisk WP
J Biol Chem; 1990 Jun; 265(16):9570-4. PubMed ID: 2188980
[TBL] [Abstract][Full Text] [Related]
3. A hybrid protein of urokinase growth-factor domain and plasminogen-activator inhibitor type 2 inhibits urokinase activity and binds to the urokinase receptor.
Ballance DJ; Marshall JM; Cottingham IR; Steven J; Berry SJ; Cederholm-Williams SA; Goodey AR; Courtney M
Eur J Biochem; 1992 Jul; 207(1):177-83. PubMed ID: 1321039
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterisation of plasminogen activator inhibitor 2 produced in Saccharomyces cerevisiae.
Steven J; Cottingham IR; Berry SJ; Chinery SA; Goodey AR; Courtney M; Ballance DJ
Eur J Biochem; 1991 Mar; 196(2):431-8. PubMed ID: 1901039
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms.
Mikus P; Urano T; Liljeström P; Ny T
Eur J Biochem; 1993 Dec; 218(3):1071-82. PubMed ID: 7506655
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of the interactions between plasminogen activator inhibitor 1 and both urokinase and tissue plasminogen activator.
Hekman CM; Loskutoff DJ
Arch Biochem Biophys; 1988 Apr; 262(1):199-210. PubMed ID: 3128176
[TBL] [Abstract][Full Text] [Related]
7. Renaturation, purification, and characterization of human plasminogen activator inhibitor type 2 (PAI-2) accumulated at high level in Escherichia coli.
Zhou A; Jiang X; Dou F; Zhu D; Xu X
J Biochem; 1997 May; 121(5):930-4. PubMed ID: 9192735
[TBL] [Abstract][Full Text] [Related]
8. Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
Bijnens AP; Knockaert I; Cousin E; Kruithof EK; Declerck PJ
Thromb Haemost; 1997 Feb; 77(2):350-6. PubMed ID: 9157595
[TBL] [Abstract][Full Text] [Related]
9. Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants.
Lawrence DA; Strandberg L; Ericson J; Ny T
J Biol Chem; 1990 Nov; 265(33):20293-301. PubMed ID: 1700786
[TBL] [Abstract][Full Text] [Related]
10. Expression of human plasminogen activator inhibitor type-1 (PAI-1) in Escherichia coli as a soluble protein comprised of active and latent forms. Isolation and crystallization of latent PAI-1.
Franke AE; Danley DE; Kaczmarek FS; Hawrylik SJ; Gerard RD; Lee SE; Geoghegan KF
Biochim Biophys Acta; 1990 Jan; 1037(1):16-23. PubMed ID: 2403813
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of natural and recombinant human plasminogen activator inhibitor-1 (PAI-1).
Alessi MC; Declerck PJ; De Mol M; Nelles L; Collen D
Eur J Biochem; 1988 Aug; 175(3):531-40. PubMed ID: 3261688
[TBL] [Abstract][Full Text] [Related]
12. On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site.
Keijer J; Linders M; Wegman JJ; Ehrlich HJ; Mertens K; Pannekoek H
Blood; 1991 Sep; 78(5):1254-61. PubMed ID: 1715220
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 binds to fibrin and inhibits tissue-type plasminogen activator-mediated fibrin dissolution.
Reilly CF; Hutzelmann JE
J Biol Chem; 1992 Aug; 267(24):17128-35. PubMed ID: 1512250
[TBL] [Abstract][Full Text] [Related]
14. Purification of recombinant plasminogen activator inhibitor-1 in the active conformation by refolding from inclusion bodies.
Lee HJ; Im H
Protein Expr Purif; 2003 Sep; 31(1):99-107. PubMed ID: 12963346
[TBL] [Abstract][Full Text] [Related]
15. Alteration of serpin specificity by a protein cofactor. Vitronectin endows plasminogen activator inhibitor 1 with thrombin inhibitory properties.
Ehrlich HJ; Gebbink RK; Keijer J; Linders M; Preissner KT; Pannekoek H
J Biol Chem; 1990 Aug; 265(22):13029-35. PubMed ID: 1695900
[TBL] [Abstract][Full Text] [Related]
16. High-level synthesis of biologically active human plasminogen activator inhibitor type 1 (PAI-1) in Escherichia coli.
Sisk WP; Davis GL; Kingsley D; Chiu AT; Reilly TM
Gene; 1990 Dec; 96(2):305-9. PubMed ID: 2269442
[TBL] [Abstract][Full Text] [Related]
17. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants of the noncatalytic chain of tissue-type plasminogen activator that modulate its association rate with plasminogen activator inhibitor-1.
de Serrano VS; Castellino FJ
J Biol Chem; 1990 Jun; 265(18):10473-8. PubMed ID: 2113057
[TBL] [Abstract][Full Text] [Related]
19. Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1.
Zeheb R; Rafferty UM; Rodriguez MA; Andreasen P; Gelehrter TD
Thromb Haemost; 1987 Dec; 58(4):1017-23. PubMed ID: 3127913
[TBL] [Abstract][Full Text] [Related]
20. Engineering plasminogen activator inhibitor 1 mutants with increased functional stability.
Lawrence DA; Olson ST; Palaniappan S; Ginsburg D
Biochemistry; 1994 Mar; 33(12):3643-8. PubMed ID: 8142362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
